Related Experiment Video

Updated: Jul 31, 2026

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging
08:31

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging

Published on: January 27, 2015

Biofilm production by clinical isolates of Candida species

C P Girish Kumar1, Thangam Menon

  • 1Department of Microbiology, Dr. A. L. Mudaliar Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai, India.

Medical Mycology
|June 30, 2006
PubMed

Insights

Most Candida bloodstream and oral isolates from immunocompromised patients form biofilms, a significant challenge for antifungal treatment. Non-albicans Candida species were more likely to be biofilm producers than Candida albicans.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Candida species are a major cause of opportunistic infections, particularly in immunocompromised individuals.
  • Biofilms formed by Candida on biomaterials like IV lines and urinary catheters are difficult to treat with conventional antifungals.

Purpose of the Study:

  • To determine the prevalence of biofilm production among clinical isolates of Candida from immunocompromised patients.
  • To compare biofilm production rates between Candida albicans and non-albicans Candida species.

Main Methods:

  • Analysis of 58 clinical Candida isolates obtained from immunocompromised patients.
  • Assessment of biofilm formation capabilities for each isolate.

Main Results:

  • A high prevalence of biofilm producers was observed: 83.3% of bloodstream isolates and 81.8% of oral isolates.
  • Biofilm-producing bloodstream isolates were significantly more common in non-albicans Candida (93.1%) compared to Candida albicans (42.9%).

Conclusions:

  • Clinical Candida isolates, especially from bloodstream infections, frequently form biofilms.
  • Non-albicans Candida species demonstrate a higher propensity for biofilm formation, posing a significant clinical challenge.

More Related Videos

Visualization of Biofilm Formation in Candida albicans Using an Automated Microfluidic Device11:14

Visualization of Biofilm Formation in Candida albicans Using an Automated Microfluidic Device

Published on: December 14, 2017

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...